FIELD: medicinal forms. SUBSTANCE: invention provides composition of synthetic membrane vesicles containing at least one release rate modulating agent other than hydrohalide and at least one biologically-active substance, vesicles being characterized by specified size distribution, controlled average size, specified volume and number of internal chambers, and controlled active ingredient release. EFFECT: enhanced therapeutic effect. 46 cl, 1 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| IMPROVED LIPOSOMES AND THEIR APPLICATION | 2008 |
|
RU2482837C2 |
| LIPID BILAYER CARRIER FOR MEDICINAL AND IMAGING AGENTS | 2011 |
|
RU2577291C2 |
| METHOD FOR EPIDURAL ADMINISTRATION OF THERAPEUTIC COMPOUNDS WITH SUSTAINING RELEASING RATE, METHOD FOR ATTENUATION OF BREATHING SUPPRESSION | 1996 |
|
RU2215522C2 |
| LIOPHILIZED LIPOSOMES | 2012 |
|
RU2648753C2 |
| COMPOSITION OF LIPID VESICLES AND METHODS OF APPLICATION | 2011 |
|
RU2595872C2 |
| NUCLEIC ACID COMPLEXES AS LIGANDS OF VESICAL ENDOTHELIAL GROWTH FACTOR (VEGF) | 1997 |
|
RU2177950C2 |
| PROLONGED RELEASE OF ANTI-INFECTIOUS AGENTS | 2006 |
|
RU2438655C2 |
| PEPTIDYL-DIACYLGLYCERIDES | 2009 |
|
RU2545347C2 |
| METHOD OF PRODUCING LIPID NANOPARTICLES FOR DRUG DELIVERY | 2012 |
|
RU2647476C2 |
| COMBINATION LIPOSOMAL COMPOSITIONS FOR CANCER TREATMENT | 2012 |
|
RU2640934C2 |
